Three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care.
As COVID-19 vaccinations increase, mask mandates recede, and pandemic-related restrictions ease, multiple myeloma care teams and patients are moving through transitioning environments—in the clinic, at home, and in their community.
In this episode, three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care. The providers discuss their perspectives on added drivers of patient stress, treatment adherence, in-clinic and virtual visits, vaccination for patients with myeloma, apps for managing medication-related changes, connecting patients with specialists via telehealth, and more
"Vaccination in myeloma patients has always been a fairly tricky field. By definition, their immune system doesn't work well, and doesn't make useful antibodies particularly well. In general, we are advising all patients to try and get the vaccine even though the response will be variable." —Adriana Rossi, MD, MSc
Guests:
Parameswaran Hari, MD, MRCP, MS
Armand J. Quick/William F. Stapp Professor of Hematology
Chief, Division of Hematology Oncology
Medical College of Wisconsin
Adriana Rossi, MD, MSc
Associate Director, Myeloma Center
Weill Cornell Medicine
Jessica Unzaga, PharmD, BCPS, BCOP
Pharmacy Clinical Coordinator
Miami Cancer Institute, Baptist Health South Florida
This podcast is produced as part of the “Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education” program. Funding & support provided by AbbVie. Learn more at accc-cancer.org/projects/returning-to-practice/overview
Podcasts:
Webinars:
Publications:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
